照护现场诊断市场规模、份额、成长分析（按产品、采购类型、技术、样本、最终用户和地区）- 2025 年至 2032 年产业预测

2023 年全球照护现场诊断市场规模为 451 亿美元，预计将从 2024 年的 492.9 亿美元成长到 2032 年的 1,004.1 亿美元，预测期内（2025-2032 年）的复合年增长率为 9.3%。

受 POC 设备技术进步、感染疾病激增以及主要企业的投资增加所推动，照护现场诊断 (POC) 市场正在经历强劲成长。由于结核病、爱滋病等感染疾病急剧上升，且患者需要立即知道检测结果，因此市场正在不断扩大。这一趋势凸显了医疗保健产业对更多以患者为中心的设备和解决方案的追求。微射流和微製造领域的创新使得 POC 诊断更便宜、更易于使用、更便携、更有效率，彻底改变了患者照护。公司正在投入越来越多的资源用于旨在增强微流体技术的研究，进一步推动发展并有望改善患者的治疗效果。总体而言，POC 诊断领域正在继续显着发展，以满足医疗保健提供者和患者的需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 专利分析
• 监管分析
• 技术分析
• 使用案例
• 客户和购买标准分析

照护现场诊断市场规模（依产品划分）及复合年增长率（2025-2032）

• 市场概览
• 血糖值监测产品
  • 血糖监测试纸
  • 血糖监测仪
  • 血糖监测采血采血针及采血装置
• 心臟代谢监测产品
  • 心臟标记检测产品
  • 血气/电解质检测产品
  • HBA1C 测试产品
• 传染病检查产品
  • 呼吸道传染病检查产品
  • 医疗保健相关感染检测产品
  • 热带疾病检测产品
  • 性行为感染传染病检测产品
• 凝血监测产品
  • PT/INR 测试产品
  • ACT/APTT检测产品
• 妊娠及不孕症检测产品
• 肿瘤/癌症标记检测产品
• 尿液检查产品
• 胆固醇检测产品
• 血液检测产品
• 药物滥用检测产品
• 甲状腺刺激素检测产品
• 大便潜血试验产品
• 其他的

按购买类型和复合年增长率分類的照护现场诊断市场规模（2025-2032 年）

• 市场概览
• 处方药检测产品
• 非处方药物检测产品

依技术分類的照护现场诊断市场规模及复合年增长率（2025-2032）

• 市场概览
• 生物化学
• 免疫检测
• 分子诊断
  • RT-PCR
  • INAAT

以样本类型和复合年增长率分類的照护现场诊断市场规模（2025-2032）

• 市场概览
• 血液样本
• 鼻腔和口咽拭子
• 尿液样本
• 其他样品

依最终用户照护现场诊断市场规模及复合年增长率（2025-2032）

• 市场概览
• 居家照护环境与自我检测
• 临床实验室
• 医院、急诊和重症监护中心
• 门诊护理设施和医生诊所
• 其他的

照护现场诊断市场规模及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

    主要企业简介

    • 雅培实验室（美国）
    • 西门子医疗股份公司（德国）
    • Quidel公司（美国）
    • F. Hoffman-La Roche Ltd.（瑞士）
    • 丹纳赫公司（美国）
    • 碧迪公司（美国）
    • Chembio Diagnostics（美国）
    • EKF诊断（英国）
    • Trinity BIoTech plc（爱尔兰）
    • 仪器实验室（美国）
    • PTS诊断公司（美国）
    • 积水诊断（美国）

结论和建议

Global Point Of Care Diagnostics Market size was valued at USD 45.1 billion in 2023 and is poised to grow from USD 49.29 billion in 2024 to USD 100.41 billion by 2032, growing at a CAGR of 9.3% during the forecast period (2025-2032).

The point of care (POC) diagnostics market is witnessing robust growth driven by technological advancements in POC devices, a surge in infectious diseases, and heightened investments from leading companies. The escalating prevalence of conditions such as tuberculosis and AIDS, alongside patients' demand for immediate test results, fuels market expansion. This trend underscores the healthcare sector's push for more patient-centric devices and solutions. With innovations in microfluidics and microfabrication, POC diagnostics have become more affordable, user-friendly, portable, and efficient, revolutionizing patient care. Companies are increasingly channeling resources into research aimed at enhancing microfluidic technology, promising improved outcomes for patients and further propelling market development. Overall, the POC diagnostics landscape continues to evolve significantly, meeting the needs of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Point Of Care Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Point Of Care Diagnostics Market Segments Analysis

Global Point Of Care Diagnostics Market is segmented by Product, Mode Of Purchase, Technology, Sample, End User and region. Based on Product, the market is segmented into Glucose Monitoring Products, Cardiometabolic Monitoring Products, Infectious Disease Testing Products, Coagulation Monitoring Products, Pregnancy & Fertility Testing Products, Tumor/Cancer Marker Testing Products, Urinalysis Testing Products, Cholesterol Testing Products, Hematology Testing Products, Drugs-Of-Abuse Testing Products, Thyroid-Stimulating Hormone Testing Products, Fecal Occult Testing Products and Other Products. Based on Mode Of Purchase, the market is segmented into Prescription-Based Testing Products and OTC Testing Products. Based on Technology, the market is segmented into Biochemistry, Immunoassays and Molecular Diagnostics. Based on Sample, the market is segmented into Blood Samples, Nasal & Oropharyngeal Swabs, Urine Samples and Other Samples. Based on End User, the market is segmented into Home Care Settings and Self-Testing, Clinical Laboratories, Hospitals, Critical Care Centers, and Urgent Care Centers, Ambulatory Care Facilities and Physician Offices and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Point Of Care Diagnostics Market

The Global Point of Care Diagnostics market is significantly propelled by ongoing technological advancements that aim to improve the usability of diagnostic devices. These innovations enhance the functionality and efficiency of point-of-care testing, allowing for quicker and more accurate results. As healthcare providers increasingly seek reliable and user-friendly solutions, the integration of cutting-edge technologies such as artificial intelligence, mobile connectivity, and portable testing equipment becomes crucial. This focus on enhancing usability not only facilitates better patient outcomes but also streamlines workflows in various clinical settings, driving the demand for advanced diagnostic tools in the global market.

Restraints in the Global Point Of Care Diagnostics Market

One of the significant restraints of the global point-of-care diagnostics market is the high initial investment costs associated with the development and implementation of diagnostic technologies. These expenses can pose a barrier for healthcare providers, particularly smaller facilities or those in developing regions, limiting their ability to adopt advanced diagnostic solutions. Additionally, the financial burden can deter investment in new technologies, hindering innovation and slowing the overall growth of the market. As a result, addressing these high upfront costs is crucial for enhancing the accessibility and widespread utilization of point-of-care diagnostic services worldwide.

Market Trends of the Global Point Of Care Diagnostics Market

The Global Point Of Care Diagnostics market is witnessing significant growth driven by advancements in personalized medicine. As healthcare shifts towards individualized treatment approaches, the demand for rapid, accurate diagnostics at the point of care is on the rise. Innovative technologies, such as portable devices and microfluidics, enable healthcare professionals to deliver real-time, tailored testing results that enhance patient outcomes. Moreover, integration with digital health platforms and data analytics is streamlining the diagnostic process, fostering greater accessibility and efficiency. As a result, stakeholders are increasingly investing in point-of-care solutions to meet the evolving needs of personalized healthcare, positioning the market for robust expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Patent Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies
• Customer And Buying Criteria Analysis

Global Point Of Care Diagnostics Market Size by Product & CAGR (2025-2032)

• Market Overview
• Glucose Monitoring Products
  • Glucose Monitoring Strips
  • Glucose Monitoring Meters
  • Glucose Monitoring Lancets & Lancing Devices
• Cardiometabolic Monitoring Products
  • Cardiac Marker Testing Products
  • Blood Gas/Electrolyte Testing Products
  • HBA1C Testing Products
• Infectious Disease Testing Products
  • Respiratory Infection Testing Products
  • Healthcare-Associated Infection Testing Products
  • Tropical Disease Testing Products
  • Sexually Transmitted Disease Testing Products
• Coagulation Monitoring Products
  • PT/INR Testing Products
  • ACT/APTT Testing Products
• Pregnancy & Fertility Testing Products
• Tumor/Cancer Marker Testing Products
• Urinalysis Testing Products
• Cholesterol Testing Products
• Hematology Testing Products
• Drugs-Of-Abuse Testing Products
• Thyroid-Stimulating Hormone Testing Products
• Fecal Occult Testing Products
• Other Products

Global Point Of Care Diagnostics Market Size by Mode Of Purchase & CAGR (2025-2032)

• Market Overview
• Prescription-Based Testing Products
• OTC Testing Products

Global Point Of Care Diagnostics Market Size by Technology & CAGR (2025-2032)

• Market Overview
• Biochemistry
• Immunoassays
• Molecular Diagnostics
  • RT-PCR
  • INAAT

Global Point Of Care Diagnostics Market Size by Sample & CAGR (2025-2032)

• Market Overview
• Blood Samples
• Nasal & Oropharyngeal Swabs
• Urine Samples
• Other Samples

Global Point Of Care Diagnostics Market Size by End User & CAGR (2025-2032)

• Market Overview
• Home Care Settings and Self-Testing
• Clinical Laboratories
• Hospitals, Critical Care Centers, and Urgent Care Centers
• Ambulatory Care Facilities and Physician Offices
• Other End Users

Global Point Of Care Diagnostics Market Size & CAGR (2025-2032)

• North America (Product, Mode Of Purchase, Technology, Sample, End User)
  • US
  • Canada
• Europe (Product, Mode Of Purchase, Technology, Sample, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Mode Of Purchase, Technology, Sample, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Mode Of Purchase, Technology, Sample, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Mode Of Purchase, Technology, Sample, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Quidel Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffman-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EKF Diagnostics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Instrumentation Laboratory (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PTS Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sekisui Diagnostics (US)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations